Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human placenta-derived 3D mesenchymal stem cell injection
- Development stage
- Unknown
- Lead developer
- Guojian Qingke Biological Medicine Technology (Beijing)
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human placenta-derived 3D mesenchymal stem cell injection is an allogeneic cell therapy product developed by Guojian Qingke Biological Medicine Technology (Beijing) for the treatment of acute ischemic stroke. The product consists of mesenchymal stem cells (MSCs) isolated from human placental tissue and expanded using a three-dimensional (3D) culture system. This 3D culture methodology is designed to better mimic the physiological niche of the cells, potentially enhancing their survival, paracrine activity, and therapeutic potency compared to traditional 2D monolayer expansion. Administered intravenously, these cells are intended to migrate to the site of brain injury, where they exert neuroprotective effects by modulating the immune response, reducing neuroinflammation, and secreting growth factors that support the survival and repair of neural tissue in the ischemic penumbra.
- Other names
- 人胎盘来源3D间充质干细胞注射液
Beyond the preview
Go deeper on human placenta-derived 3D mesenchymal stem cell injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human placenta-derived 3D mesenchymal stem cell injection.